Solix BioSystems Appoints Austin Maguire to President and CEO Position
Fort Collins, Colorado – January 16, 2014 – Solix BioSystems, Inc. (“Solix”), a leader in photosynthetic algal technology, today announced the appointment of Austin Maguire as its President and Chief Executive Officer. Maguire brings over 25 years of experience in operations and executive management to Solix at a time when the company is shifting towards commercialization and scaling its operations to satisfy the growing demand for natural high-value, specialty algal products for the nutrition, personal care and aquaculture markets.
“I am delighted that Austin has joined the team at Solix,” says Ilya Golubovich of I2BF Global Ventures, a major investor in Solix. “Austin brings a demonstrated track record of leadership success in the development, scale-up and global commercialization of new high-value specialty food ingredients. His extensive experience will be instrumental in ensuring the success of Solix’s first commercial product launches.”
Prior to joining Solix, Maguire was most recently the President of Calera Corporation, a Khosla Ventures-backed carbon dioxide sequestration company, where he led the scale-up of the company’s technology and the development of key strategic alliances. Prior to Calera, Maguire served as the President of Tate & Lyle Sucralose Inc., where he led the global SPLENDA® Sucralose sweetener business for eleven years until 2008. At Tate & Lyle, Maguire was also a member of the Group’s Senior Operations Management Committee. Earlier positions in Maguire’s Tate & Lyle career involved living in the U.S., Canada and the U.K. and included progressive increases in global responsibility such as Operations and Managing Director level positions in the U.K. Maguire began his career with Irish Refining Company as a process and project engineer in their Exxon managed oil refinery and later moved to Angus Fine Chemicals, an American/French contract manufacturing joint venture. Maguire holds a chemical engineering degree from University College Dublin, Ireland.
“Solix has already proven its technology’s versatility at scale, and I am excited about moving the company forward to the commercialization phase and delivering innovative natural microalgae-derived products that meet growing consumer demand” said Maguire.
Joel Butler, former CEO, will continue at Solix in the new role of Chief Strategic Alliance Officer.
Source: Solix Biosystems